1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Liposarcoma Global Clinical Trials Review, H1, 2015

Liposarcoma Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 77 pages

Liposarcoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Liposarcoma Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Liposarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Liposarcoma 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Liposarcoma Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Zeltia, S.A. 34
Clinical Trial Overview of Zeltia, S.A. 34
Johnson and Johnson 35
Clinical Trial Overview of Johnson and Johnson 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Merck and Co., Inc. 38
Clinical Trial Overview of Merck and Co., Inc. 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
European Organization for Research and Treatment of Cancer 42
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 42
Fred Hutchinson Cancer Research Center 43
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 43
Memorial Sloan Kettering Cancer Center 44
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 44
University of Heidelberg 45
Clinical Trial Overview of University of Heidelberg 45
Institut Bergonie 46
Clinical Trial Overview of Institut Bergonie 46
Grupo Espanol de Investigacion en Sarcomas 47
Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas 47
Northwestern University 48
Clinical Trial Overview of Northwestern University 48
Children's Oncology Group 49
Clinical Trial Overview of Children's Oncology Group 49
Five Key Clinical Profiles 50
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

List of Tables
Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Liposarcoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Liposarcoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Liposarcoma Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2015* 34
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 35
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 38
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 39
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 40
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 41
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 42
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 43
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 44
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015* 45
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Bergonie, 2015* 46
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015* 47
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 48
Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015* 49

List of Figures
Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.